Related references
Note: Only part of the references are listed.Enhancement of the Immunogenicity of Synthetic Carbohydrate Vaccines by Chemical Modifications of STn Antigen
Fan Yang et al.
ACS CHEMICAL BIOLOGY (2011)
Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam(3)CysSer
Brendan L. Wilkinson et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Role of mucins in the skin during benign and malignant conditions
Subhankar Chakraborty et al.
CANCER LETTERS (2011)
Synthetic Antitumor Vaccines from Tetanus Toxoid Conjugates of MUC1 Glycopeptides with the Thomsen-Friedenreich Antigen and a Fluorine-Substituted Analogue
Anja Hoffmann-Roder et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Fully Synthetic Vaccines Consisting of Tumor-Associated MUC1 Glycopeptides and a Lipopeptide Ligand of the Toll-like Receptor 2
Anton Kaiser et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
The membrane-bound mucins: From cell signalling to transcriptional regulation and expression in epithelial cancers
Nicolas Jonckheere et al.
BIOCHIMIE (2010)
Fluorinated Glycosyl Amino Acids for Mucin-Like Glycopeptide Antigen Analogues
Sarah Wagner et al.
CHEMISTRY-A EUROPEAN JOURNAL (2010)
Fluorine in health care Organofluorine containing blockbuster drugs
David O'Hagan
JOURNAL OF FLUORINE CHEMISTRY (2010)
A Synthetic Vaccine Consisting of a Tumor-Associated Sialyl-T-N-MUC1 Tandem-Repeat Glycopeptide and Tetanus Toxoid: Induction of a Strong and Highly Selective Immune Response
Anton Kaiser et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Increasing the Antigenicity of Synthetic Tumor-Associated Carbohydrate Antigens by Targeting Toll-Like Receptors
Sampat Ingale et al.
CHEMBIOCHEM (2009)
Potent Fluoro-oligosaccharide Probes of Adhesion in Toxoplasmosis
Sarah A. Allman et al.
CHEMBIOCHEM (2009)
Immunotherapy for cancer: synthetic carbohydrate-based vaccines
Therese Buskas et al.
CHEMICAL COMMUNICATIONS (2009)
Recent insights into the biological roles of mucin-type O-glycosylation
E. Tian et al.
GLYCOCONJUGATE JOURNAL (2009)
Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes
Tanja Ninkovic et al.
MOLECULAR IMMUNOLOGY (2009)
Syntheses of fluorine-containing mucin core 2/core 6 structures using novel fluorinated glucosaminyl donors
Jun Xue et al.
TETRAHEDRON (2009)
Mucins in cancer: function, prognosis and therapy
Donald W. Kufe
NATURE REVIEWS CANCER (2009)
Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and a T-cell epitope for the induction of a highly specific humoral immune response
Ulrika Westerlind et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
Structure and function of the cell surface (tethered) mucins
Christine L. Hattrup et al.
ANNUAL REVIEW OF PHYSIOLOGY (2008)
Understanding organofluorine chemistry. An introduction to the C-F bond
David O'Hagan
CHEMICAL SOCIETY REVIEWS (2008)
Robust immune responses elicited by a fully synthetic three-component vaccine
Sampat Ingale et al.
NATURE CHEMICAL BIOLOGY (2007)
Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat
Mads A. Tarp et al.
GLYCOBIOLOGY (2007)
Synthesis of fluorinated mucin core 2 branched oligosaccharides with the potential of novel substrates and enzyme inhibitors for glycosyltransferases and sulfotransferases
J Xia et al.
JOURNAL OF ORGANIC CHEMISTRY (2006)
Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance
AL Sorensen et al.
GLYCOBIOLOGY (2006)
A fully synthetic vaccine consisting of a tumor-associated glycopeptide antigen and a T-Cell epitope for the induction of a highly specific humoral immune response
S Dziadek et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Biomimetic synthesis of the tumor-associated (2,3)-sialyl-T antigen and its incorporation into glycopeptide antigens from the mucins MUC1 and MUC4
S Dziadek et al.
CHEMISTRY-A EUROPEAN JOURNAL (2004)
MUC1-derived glycopeptide libraries with improved MHC anchors are strong antigens and prime mouse T cells for proliferative responses to lysates of human breast cancer tissue
M Gad et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Share Paper
